Skip to content

The cardiometabolic significance of post-dexamethasone cortisol levels below the MACS threshold in adrenal incidentaloma

Sep 2026 · Endocrine · Vol 91 · 0 citations · 22 references
Medicine

TL;DR

The findings suggest that patients below the current MACS threshold may not represent a metabolically homogeneous or uniformly benign population and support further prospective investigation of cardiometabolic risk across the continuum of post-DST cortisol levels.

View source

Similar papers

Oct 2026

Association of Post-Dexamethasone Cortisol With Cardiovascular and Metabolic Comorbidities in Patients With Nonfunctioning Adrenal Adenomas.

Higher post-DST cortisol within the suppressed range was independently associated with documented ASCVD and showed substantial discrimination, which support a cardiometabolic gradient below the mild autonomous cortisol secretion threshold but do not establish a diagnostic cutoff.

M. Görgülü, Murat Çalapkulu, E. Üçgül et al. · 0 citations
Sep 2026

Cardiometabolic benefits after adrenalectomy for mild autonomous cortisol secretion.

BACKGROUND Mild autonomous cortisol secretion causes substantial cardiometabolic morbidity, yet evidence for benefits following adrenalectomy remains mixed. Prior studies are limited by small sample sizes and heterogeneous definitions. This study evaluates the metabolic impact of adrenalectomy compared with nonoperativ...

Alexis Korman, J. Done, Arden Stromnes et al. · 0 citations
Open access Sep 2026

Adrenal incidentalomas: 1 mg dexamethasone test result in the context of cardiometabolic risk.

Post-DST cortisol concentrations below the standard cutoff may be associated with cardiometabolic comorbidities in patients with adrenal incidentalomas, and these findings should be interpreted with caution and require confirmation in prospective studies.

J. Kokoszka, M. Opalińska, Magdalena Fiema et al. · 0 citations
Open access Sep 2026

Plasma cortisol cut-off concentrations using the dexamethasone suppression test in patients with adrenal incidentalomas

Purpose Assessment of cortisol secretion in patients with adrenal incidentalomas remains challenging. We evaluated the guideline-recommended cortisol cut-off value for cortisol suppression (50 nmol/L) following a 1 mg overnight dexamethasone suppression test (DST) against a control-derived threshold and compared patien...

N. Jørgensen, S. Borresen, L. Hilsted et al. · 0 citations
Open access Oct 2026

Post-dexamethasone cortisol levels in non-functioning adrenal incidentalomas: a pooled individual participant data analysis

Comparing F-1mgDST distributions between individuals with NFAI and population-based controls and to explore whether alternative F-1mgDST thresholds would meaningfully modify patient classification found no F-1mgDST threshold with an accuracy exceeding 60% for distinguishing controls from patients with NFAI.

I. Chiodini, V. Favero, C. Eller-Vainicher et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.